1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Aeglea Biotherapeutics Inc (AGLE) President & CEO Anthony G. Quinn Bought $196,535 of Shares

June 14, 2019 | About:

President & CEO of Aeglea Biotherapeutics Inc (NASDAQ:AGLE) Anthony G. Quinn bought 31,905 shares of AGLE on 06/14/2019 at an average price of $6.16 a share. The total cost of this purchase was $196,535.

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer. Aeglea BioTherapeutics Inc has a market cap of $178.280 million; its shares were traded at around $6.18 with and P/S ratio of 53.73.

CEO Recent Trades:

  • President & CEO Anthony G. Quinn bought 31,905 shares of AGLE stock on 06/14/2019 at the average price of $6.16. The price of the stock has increased by 0.32% since.
  • President & CEO Anthony G. Quinn bought 26,592 shares of AGLE stock on 05/22/2019 at the average price of $6.77. The price of the stock has decreased by 8.71% since.
  • President & CEO Anthony G. Quinn bought 18,713 shares of AGLE stock on 05/17/2019 at the average price of $6.75. The price of the stock has decreased by 8.44% since.

For the complete insider trading history of AGLE, click here

.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)